Phase 2 Trial of Pembrolizumab, Lenalidomide and Dexamethasone for Initial Therapy of Newly Diagnosed Multiple Myeloma Eligible for Stem Cell Transplantation
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 13 Jul 2017
At a glance
- Drugs Pembrolizumab (Primary) ; Dexamethasone; Lenalidomide
- Indications Multiple myeloma
- Focus Therapeutic Use
- 10 Jul 2017 Status changed from recruiting to active, no longer recruiting.
- 16 Sep 2016 Status changed from not yet recruiting to recruiting.
- 08 Sep 2016 New trial record